Supernus Pharmaceuticals (GB:0LB2)
LSE:0LB2

Supernus Pharmaceuticals (0LB2) Similar Shares

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Supernus Pharmaceuticals
$1.69B
-108.16
2.06%
2 Buy
1 Hold
0 Sell
Moderate Buy
$40.67
Alkermes
$4.59B
16.52
-0.96%
7 Buy
5 Hold
0 Sell
Moderate Buy
$35.91
Arvinas Holding Company
$2.02B
-4.98
35.26%
13 Buy
2 Hold
0 Sell
Strong Buy
$65.29
PTC Therapeutics
$2.57B
-4.44
-12.00%
5 Buy
4 Hold
3 Sell
Hold
$42.88
BioMarin Pharmaceutical
$16.06B
79.17
-2.27%
9 Buy
4 Hold
0 Sell
Moderate Buy
$105.08
Supernus Pharmaceuticals
$1.69B
-108.16
2.06%
2 Buy
1 Hold
0 Sell
Moderate Buy
$40.67

Performance Comparison

Ticker
Company Name
Price
$ Change
% Change
SUPN
Supernus Pharmaceuticals
30.75
0.62
2.06%
ALKS
Alkermes
27.88
-0.27
-0.96%
ARVN
Arvinas Holding Company
29.65
7.73
35.26%
PTCT
PTC Therapeutics
34.09
-4.65
-12.00%
BMRN
BioMarin Pharmaceutical
84.59
-1.97
-2.28%
GB:0LB2
Supernus Pharmaceuticals
30.71
0.60
1.98%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis